New device aims to stop aneurysm growth without open surgery
NCT ID NCT05133492
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the Nectero EAST System in 46 people with abdominal aortic aneurysms (AAA). The goal is to see if it is safe and can stop the aneurysm from growing, reducing the need for major surgery. Participants receive the device through a catheter, and doctors monitor their aneurysm size over 36 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AAA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Auckland City Hospital
Auckland, New Zealand
-
Pablo Tabon Uribe Hospital
Medellín, Antioquia, Colombia
-
Pauls Stradins Clinical University Hospital
Riga, Latvia
-
Prince of Wales Private Hospital
Randwick, New South Wales, 2031, Australia
-
Queen Mary Hospital
Hong Kong, Southern District, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves replace CT scans for aortic aneurysm monitoring?
- Can a stent-graft keep aortic aneurysms in check for years? a long-term follow-up study aims to find out.
- Aneurysm repair may stiffen arteries — a study asks what that means for the heart
- Rehab after aneurysm surgery: could a 3-Week program boost heart and lung fitness?
- Nerve block may offer safer pain relief after major aortic surgery
- New device aims to seal aortic aneurysms without open surgery